Evaluation for the withdrawal syndrome from γ-hydroxybutyric acid (GHB), γ-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 545-558

  Quang, Lawrence S ^a   Colombo, Giancarlo ^b   Lobina, Carla ^b   Maccioni, Paola ^b,c   Orru, Alessandro ^b,c   Gessa, Gian Luigi ^b   Maher, Timothy J ^d   Carai, Mauro A M ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CNR   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

1,4 butanediol (1,4 BD); GHB sensitive (GHB S) rats; Sardinian alcohol preferring (sP) rats; Withdrawal syndrome; butyrolactone (GBL); hydroxybutyric acid (GHB)

Indexed keywords

1,4 BUTANEDIOL; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; GAMMA BUTYROLACTONE;

ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; AUDIOGENIC SEIZURE; AUDITORY STIMULATION; CHRONIC DRUG ADMINISTRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; EXPLORATORY BEHAVIOR; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PROVOCATION TEST; RAT; RAT STRAIN; SCORING SYSTEM; WITHDRAWAL SYNDROME;

RODENTIA;

EID: 33749562549     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.055     Document Type: Conference Paper

References (47)

1. GALLOWAY, G.P., S.L. FREDERICK & F. STAGGERS JR. 1994. Physical dependence on sodium oxybate [letter]. Lancet 343: 57.
2. FRIEDMAN, J., R. WESTLAKE & M. FURMAN. 1996. 'Grievous bodily harm': gamma hydroxybutyrate abuse leading to Wernicke-Korsakoff syndrome. Neurology 46: 469-471.
3. DYER, J.E. & K.M. ANDREWS. 1997. Gamma hydroxybutyrate withdrawal. J. Toxicol. Clin. Toxicol. 92: 89-96.
4. GALLOWAY, G.P., S.L. FREDERICK & F.E. STAGGERS Jr., et al. 1997. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92: 89-96.
5. HERNANDEZ, M., C.H. MCDANIEL, C.D. COSTANZA, et al. 1998. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid. Am. J. Drug Alcohol Abuse 24: 179-183.
6. ADDOLORATO, G., F. CAPUTO, E. CAPRISTO, et al. 1999. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin. Neuropharmacol. 22: 60-62.
7. CRAIG, K., H.F. GOMEZ, J.L. MCMANUS, et al. 2000. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J. Emerg. Med. 18: 64-70.
8. HUTTO, B., A. FAIRCHILD & R. BRIGHT. 2000. γ-Hydroxybutyrate withdrawal and chloral hydrate. Am. J. Psychiatry 157: 10.
9. MIGLANI, J.S., K.Y. KIM & R. CHAHIL. 2000. Gamma-hydroxybutyrate withdrawal delirium: a case report. Gen. Hosp. Psychiatry 22: 213-215.
10. PRICE, G. 2000. In-patient detoxification after GHB dependence. Br. J. Psychiatry 177: 181.
11. GREENE, T., T. DOUGHERTY & A. RODI. 2000. Gamma-butyrolactone withdrawal presenting as acute psychosis. J. Tox. Clin. Tox. 37: 651.
12. SHARMA, A.N., L. NELSON & R.S. HOFFMAN. 2000. Severe gamma-butyrolactone withdrawal. J. Tox. Clin. Tox. 38: 535.
13. CATALANO, M.C., J.M. GLASS, G. CATALANO, et al. 2001. Gamma butyrolactone (GBL) withdrawal syndromes. Psychosomatics 42: 83-88.
14. MULLINS, M.E. & S.C. FITZMAURICE. 2001. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal. J. Emerg. Med. 20: 418-420.
15. SHARMA, A.N. & M.H. LOMBARDI. 2001. Management of gamma-hydroxybutyrate withdrawal, Ann. Emerg. Med. 38: 605-607.
16. SU, M., S.J. TRAUB, E. HUSSAIN, et al. 2001. 1,4-Butanediol withdrawal complicated by urinary retention. J. Toxicol. Clin. Toxicol. 39: 542.
17. BOWLES, T.M., R.W. SOMMI & M. AMIRI. 2001. Successful management of prolonged γ-hydroxybutyrate and alcohol withdrawal. Pharmacotherapy 21: 254-257.
18. DYER, J.E., B. ROTH & B.A. HYMA. 2001. Gamma-hydroxybutyrate withdrawal syndrome. Ann. Emerg. Med. 37: 147-153.
19. MAHR, G., C.L. BISHOP & D.J. ORRINGER. 2001. Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse. Psychosomatics 42: 439-440.
20. MCDANIEL, C.H. & K.A. MIOTTO. 2001. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J. Psychoactive Drugs 33: 143-149.
21. MIOTTO, K., J. DARAKJIAN, J. BASCH, et al. 2001. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am. J. Addict. 10: 232-241.
22. SCHNEIR, A.B., B.T. LY & R.F. CLARK. 2001. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol. J. Emerg. Med. 21: 31-33.
23. SIVILOTTI, M.L., M.J. BURNS, C.K. AARON, et al. 2001. Pentobarbital for severe gamma-butyrolactone withdrawal. Ann. Emerg. Med. 38: 660-665.
24. MYCYK, M.B., C. WILEMON & S.E. AKS. 2001. Two cases of withdrawal from 1,4-butanediol use. Ann. Emerg. Med. 38: 345-346.
25. CHIN, R.L. 2001. A case of severe withdrawal from gamma-hydroxybutyrate. Ann. Emerg. Med. 37: 551-552.
26. ZVOSEC, D.L., S.W. SMITH, J.D. MCCUTCHEON, et al. 2001. Adverse events, including death, associated with the use of 1,4-butanediol. N. Engl. J. Med. 344: 87-94.
27. HAROLD, A.H. & K.B. SNEED. 2002. Treatment of a young adult taking gamma-butyrolactone (GBL) in a primary care clinic. J. Am. Board Family Pract. 15: 161-163.
28. MCDONOUGH, M., N. KENNEDY, A. GLASPER, et al. 2004. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend. 75: 3-9.
29. ZVOSEC, D.L. & S.W. SMITH. 2004. γ-Hydroxybutyrate addiction and withdrawal: from the γ-hydroxybutyrate addiction study. Ann. Emerg. Med. 44: pS91.
30. CHEW, G. & A. FERNANDO III. 2004. Epileptic seizure in GHB withdrawal. Australas. Psychiatry 12: 410-411.
31. MAJCHROWICZ, E. 1975. Induction of physical dependence upon ethanol and the associated behavioural changes in rats. Psychopharmacologia 43: 245-254.
32. LAL, H., C.M. HARRIS, D. BENJAMIN, et al. 1988. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J. Pharmacol. Exp. Ther. 247: 508-518.
33. COLOMBO, G., R. AGABIO M.A.M. CARAI, et al. 2000. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol Clin. Exp. Res. 24(1): 58-66.
34. BANIA, T.C., T. ASHAR, G. PRESS, et al. 2003. Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model. Acad. Emerg. Med. 10: 697-704.
35. COOK, C.D., M.D. ACETO, A. COOP, et al. 2002. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology 160: 99-106.
36. LOBINA, C., G. COLOMBO, G. BRUNETTI, et al. 2001. Procedure of bidirectional selective outbreeding for production of two rat lines differing in sensitivity to the sedative/hypnotic effect of gamma-hydroxybutyric acid. Brain Res. Brain Res. Protoc. 8: 74-81.
37. COLOMBO, G., C. LOBINA, R. AGABIO, et al. 2001. Selective breeding of two rat lines differing in sensitivity to GHB and baclofen. Brain Res. 902: 127-130.
38. LOBINA, C., G. COLOMBO, G.L. GESSA, et al. 2004. Completion by the 10th Generation of the Bidirectional Selective Breeding of GHB-Sensitive and GHB-Resistant Rats. Brain Res. Brain Res. Protoc. 13: 53-56.
39. LOBINA, C., G. COLOMBO, G.L. GESSA, et al. 2005. Different sensitivity to the motor in coordinating effects of gamma-hydroxybutyric acid (GHB) and baclofen in GHB-sensitive and GHB-resistant rats. Brain Res. 1033: 109-112.
40. COLOMBO, G. 1997. Ethanol drinking behaviour in Sardinian alcohol preferring rats. Alcohol Alcohol. 32: 443-453.
41. COLOMBO, G., R. AGABIO, C. LOBINA, et al. 1998. High sensitivity to gamma-hydroxybutyric acid in ethanol-preferring sP rats. Alcohol Alcohol. 33: 121-125.
42. COLOMBO, G., R. AGABIO, G. DIAZ, et al. 1998. Gamma-hydroxybutyric acid intake in ethanol-preferring sP and -non preferring sNP rats. Physiol. Behav. 64: 197-202.
43. LINGENHOEHL, K., R. BROM, J. HEID, et al. 1999. γ-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors. Neuropharmacology 38:1667-1673.
44. B receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid. Eur. J. Pharmacol. 428: 315-321.
45. B receptors via its conversion into γ-hydroxybutyric acid. Eur. J. Pharmacol. 441: 157-163.
46. B receptor antagonist on γ-hydroxybutyric acid (GHB) mortality in mice. Ann. Emerg. Med. 45: 614-619.
47. QUANG, L.S., M.C. DESAI, J.C. KRANER, et al. 2002. Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice. Ann. N. Y. Acad. Sci. 965: 461-472.